M01 tool: an automated, comprehensive computational tool for generating small molecule-peptide hybrids and docking them into curated protein structures.
Mahsa Sheikholeslami, Mohammad Hasan Nazari, Afshin Fassihi
{"title":"M01 tool: an automated, comprehensive computational tool for generating small molecule-peptide hybrids and docking them into curated protein structures.","authors":"Mahsa Sheikholeslami, Mohammad Hasan Nazari, Afshin Fassihi","doi":"10.1186/s12859-025-06120-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The field of computational drug design is undergoing rapid advancements, highlighting the need for innovative methods to enhance the efficiency and accuracy of calculating ligand-receptor interactions. In this context, we introduce the M01 tool, a comprehensive computational package designed to facilitate the generation and docking of small molecule-peptide hybrids. M01 integrates several established tools, such as RDKit and EasyDock, into a user-friendly platform that automates the workflow from hybrid generation to docking simulations. This tool is particularly beneficial for researchers with limited chemistry expertise, helping them leverage advanced computational techniques.</p><p><strong>Results: </strong>The M01 tool features an intuitive interface for visualizing molecules and selecting connection points in generating new ligands. It also offers automated receptor preparation using UniProt or PDB IDs and generates default docking configuration files. Furthermore, it includes ligand preparation and docking capabilities through EasyDock and calculates molecular descriptors relevant to drug-likeness properties. Validation studies with peptide-alkoxyamine hybrids demonstrated the tool's effectiveness, generating over 14,000 unique hybrid molecules and showcasing its versatility in drug design applications.</p><p><strong>Conclusions: </strong>The M01 tool represents a significant advancement in computational drug design, streamlining the process of creating hybrid molecules and conducting docking studies. Its ability to automate complex workflows and provide essential molecular insights can empower researchers and enhance the development of novel therapeutics, ultimately contributing to more efficient drug discovery efforts.</p>","PeriodicalId":8958,"journal":{"name":"BMC Bioinformatics","volume":"26 1","pages":"102"},"PeriodicalIF":2.9000,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11995494/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Bioinformatics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1186/s12859-025-06120-5","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The field of computational drug design is undergoing rapid advancements, highlighting the need for innovative methods to enhance the efficiency and accuracy of calculating ligand-receptor interactions. In this context, we introduce the M01 tool, a comprehensive computational package designed to facilitate the generation and docking of small molecule-peptide hybrids. M01 integrates several established tools, such as RDKit and EasyDock, into a user-friendly platform that automates the workflow from hybrid generation to docking simulations. This tool is particularly beneficial for researchers with limited chemistry expertise, helping them leverage advanced computational techniques.
Results: The M01 tool features an intuitive interface for visualizing molecules and selecting connection points in generating new ligands. It also offers automated receptor preparation using UniProt or PDB IDs and generates default docking configuration files. Furthermore, it includes ligand preparation and docking capabilities through EasyDock and calculates molecular descriptors relevant to drug-likeness properties. Validation studies with peptide-alkoxyamine hybrids demonstrated the tool's effectiveness, generating over 14,000 unique hybrid molecules and showcasing its versatility in drug design applications.
Conclusions: The M01 tool represents a significant advancement in computational drug design, streamlining the process of creating hybrid molecules and conducting docking studies. Its ability to automate complex workflows and provide essential molecular insights can empower researchers and enhance the development of novel therapeutics, ultimately contributing to more efficient drug discovery efforts.
期刊介绍:
BMC Bioinformatics is an open access, peer-reviewed journal that considers articles on all aspects of the development, testing and novel application of computational and statistical methods for the modeling and analysis of all kinds of biological data, as well as other areas of computational biology.
BMC Bioinformatics is part of the BMC series which publishes subject-specific journals focused on the needs of individual research communities across all areas of biology and medicine. We offer an efficient, fair and friendly peer review service, and are committed to publishing all sound science, provided that there is some advance in knowledge presented by the work.